Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 19, 2022

50715_rns_2022-07-19_a02365f6-a4d6-4906-aeeb-0e49aebb4f50.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

19 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Descriptionof products Nature ofdealings Number ofreferencesecurities towhich thederivativesrelate Maturity date/ closing outdate Referenceprice Total amountpaid /received Resultantbalance(includingthose of anyperson withwhom there isan agreementorunderstanding)
CICC FinancialTrading Limited 18 July 2022 Derivatives Other types ofproducts Closing out of aderivative contract 2,000 20 July 2023 $24.0547 $48,109.4600 936,000
Derivatives Other types ofproducts Closing out of aderivative contract 2,000 17 April 2023 $24.0656 $48,131.1500 388,000

End

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.